Works about INFLIXIMAB

Results: 3338

How to modulate inflammatory cytokines in liver diseases.

Published in:

Liver International, 2006, v. 26, n. 9, p. 1029, doi. 10.1111/j.1478-3231.2006.01339.x

By:

Tilg, Herbert;
Kaser, Arthur;
Moschen, Alexander R.

Publication type:

Article

Adjunctive infliximab not effective for symptom reduction in bipolar depression.

Published in:: Brown University Psychopharmacology Update, 2019, v. 30, n. 8, p. 1, doi. 10.1002/pu.30455
Publication type:: Article

Stable expression of infliximab in CRISPR/Cas9-mediated BAK1-deficient CHO cells.

Published in:

Biotechnology Letters, 2018, v. 40, n. 8, p. 1209, doi. 10.1007/s10529-018-2578-4

By:

Miao, Zhi;
Li, Qian;
Zhao, Jian;
Wang, Peng;
Wang, Lei;
He, Hong-Peng;
Wang, Nan;
Zhou, Hao;
Zhang, Tong-Cun;
Luo, Xue-Gang

Publication type:

Article

RETRACTION: Infliximab Substantially Re‐Silenced Wnt/Β‐Catenin Signaling and Ameliorated Doxorubicin‐Induced Cardiomyopathy in Rats.

Published in:: 2025
Publication type:: Correction Notice

Infliximab substantially re‐silenced Wnt/β‐catenin signaling and ameliorated doxorubicin‐induced cardiomyopathy in rats.

Published in:

Journal of Biochemical & Molecular Toxicology, 2023, v. 37, n. 5, p. 1, doi. 10.1002/jbt.23312

By:

Mohamed, Hoda E.;
Askar, Mervat E.;
Shaheen, Mohamed A.;
Salama, Alaa E.;
Idris, Reham A.;
Younis, Nahla N.

Publication type:

Article

Serum cytokines and bone metabolic markers in patients with rheumatoid arthritis treated with biological disease modifying anti-rheumatic drugs.

Published in:

Clinical Rheumatology, 2023, v. 42, n. 3, p. 721, doi. 10.1007/s10067-022-06390-x

By:

Tamai, Hiroya;
Nishina, Naoshi;
Kikuchi, Jun;
Izumi, Keisuke;
Otomo, Kotaro;
Yoshimoto, Keiko;
Yamaoka, Kunihiro;
Takeuchi, Tsutomu;
Kaneko, Yuko

Publication type:

Article

Improvement in disease activity among patients with rheumatoid arthritis who switched from intravenous infliximab to intravenous golimumab in the ACR RISE registry.

Published in:

Clinical Rheumatology, 2022, v. 41, n. 8, p. 2319, doi. 10.1007/s10067-022-06116-z

By:

Tesser, John;
Lin, Iris;
Shiff, Natalie J.;
Chakravarty, Soumya D.;
Schmajuk, Gabriela;
Hammam, Nevin;
Desai, Sheetal

Publication type:

Article

Ulcerative cutaneous sarcoidosis successfully treated with infliximab.

Published in:

2021

By:

Bukiej, Aleksandra;
Wu, John;
Sequeira, Winston

Publication type:

Case Study

Infliximab for the treatment of refractory polyarteritis nodosa.

Published in:

Clinical Rheumatology, 2019, v. 38, n. 10, p. 2825, doi. 10.1007/s10067-019-04474-9

By:

Ginsberg, Shira;
Rosner, Itzhak;
Slobodin, Gleb;
Rozenbaum, Michael;
Kaly, Lisa;
Jiries, Nizar;
Boulman, Nina;
Awisat, Abid;
Hussein, Haya;
Novofastovski, Irina;
Silawy, Amal;
Rimar, Doron

Publication type:

Article

Comparative efficacy between adalimumab and infliximab in the treatment of non-infectious intermediate uveitis, posterior uveitis, and panuveitis: a retrospective observational study of 107 patients.

Published in:

Clinical Rheumatology, 2019, v. 38, n. 2, p. 407, doi. 10.1007/s10067-018-4228-6

By:

Fabiani, Claudia;
Vitale, Antonio;
Rigante, Donato;
Emmi, Giacomo;
Bitossi, Alice;
Lopalco, Giuseppe;
Sota, Jurgen;
Guerriero, Silvana;
Orlando, Ida;
Gentileschi, Stefano;
Iannone, Florenzo;
Frediani, Bruno;
Galeazzi, Mauro;
Vannozzi, Lorenzo;
Tosi, Gian Marco;
Cantarini, Luca

Publication type:

Article

Long-term retention rates of adalimumab and infliximab in non-infectious intermediate, posterior, and panuveitis.

Published in:

Clinical Rheumatology, 2019, v. 38, n. 1, p. 63, doi. 10.1007/s10067-018-4069-3

By:

Fabiani, Claudia;
Vitale, Antonio;
Emmi, Giacomo;
Bitossi, Alice;
Lopalco, Giuseppe;
Sota, Jurgen;
Guerriero, Silvana;
Orlando, Ida;
Capozzoli, Marco;
Fusco, Fiorella;
Rana, Francesco;
Iannone, Florenzo;
Frediani, Bruno;
Galeazzi, Mauro;
Vannozzi, Lorenzo;
Tosi, Gian Marco;
Cantarini, Luca

Publication type:

Article

Analysis of biomarker serum levels in IVIG and infliximab refractory Kawasaki disease patients.

Published in:

Clinical Rheumatology, 2018, v. 37, n. 7, p. 1937, doi. 10.1007/s10067-017-3952-7

By:

Hachiya, Akira;
Kobayashi, Norimoto;
Matsuzaki, Satoshi;
Takeuchi, Yusuke;
Akazawa, Yohei;
Shigemura, Tomonari;
Motoki, Noriko;
Masumoto, Junya;
Agematsu, Kazunaga

Publication type:

Article

Predictors of sustained clinical response in patients with Behçet’s disease-related uveitis treated with infliximab and adalimumab.

Published in:

Clinical Rheumatology, 2018, v. 37, n. 6, p. 1715, doi. 10.1007/s10067-018-4092-4

By:

Fabiani, Claudia;
Vitale, Antonio;
Rigante, Donato;
Emmi, Giacomo;
Lopalco, Giuseppe;
Sota, Jurgen;
Vannozzi, Lorenzo;
di Scala, Gerardo;
Guerriero, Silvana;
Orlando, Ida;
Franceschini, Rossella;
Capozzoli, Marco;
Frediani, Bruno;
Galeazzi, Mauro;
Iannone, Florenzo;
Tosi, Gian Marco;
Cantarini, Luca

Publication type:

Article

High burden of adverse events is associated with reduced remission rates in early rheumatoid arthritis.

Published in:

Clinical Rheumatology, 2018, v. 37, n. 6, p. 1689, doi. 10.1007/s10067-017-3958-1

By:

Kuusalo, Laura;
Puolakka, Kari;
Kautiainen, Hannu;
Karjalainen, Anna;
Malmi, Timo;
Paimela, Leena;
Leirisalo-Repo, Marjatta;
Rantalaiho, Vappu;
for the NEO-RACo Study Group

Publication type:

Article

TNFα blockers followed by continuation of sulfasalazine and methotrexate combination: a retrospective study on cost saving options of treatment in Spondyloarthritis.

Published in:

Clinical Rheumatology, 2017, v. 36, n. 10, p. 2243, doi. 10.1007/s10067-017-3726-2

By:

Nair, Aswin;
Sandhya, P.;
Yadav, Bijesh;
Danda, Debashish

Publication type:

Article

Therapeutic drug monitoring (TDM) as a tool in the switch from infliximab innovator to biosimilar in rheumatic patients: results of a 12-month observational prospective cohort study.

Published in:

Clinical Rheumatology, 2017, v. 36, n. 9, p. 2129, doi. 10.1007/s10067-017-3686-6

By:

Schmitz, E.;
Benoy - De Keuster, S.;
Meier, A.;
Scharnhorst, V.;
Traksel, R.;
Broeren, M.;
Derijks, L.

Publication type:

Article

Maintenance of efficacy and safety with subcutaneous golimumab in rheumatoid arthritis patients with low disease activity who previously received TNF inhibitors.

Published in:

Clinical Rheumatology, 2017, v. 36, n. 4, p. 941, doi. 10.1007/s10067-016-3502-8

By:

Wakabayashi, Hiroki;
Inada, Hitoshi;
Nishioka, Yosuke;
Hasegawa, Masahiro;
Sudo, Akihiro;
Nishioka, Kusuki

Publication type:

Article

Biosimilars in rheumatic diseases: structural and functional variability that may impact clinical and regulatory decisions.

Published in:

Clinical Rheumatology, 2016, v. 35, n. 12, p. 2869, doi. 10.1007/s10067-016-3430-7

By:

Lakhanpal, Amit;
Brahn, Ernest

Publication type:

Article

Premedication prevents infusion reactions and improves retention rate during infliximab treatment.

Published in:

Clinical Rheumatology, 2016, v. 35, n. 11, p. 2841, doi. 10.1007/s10067-016-3351-5

By:

Bartoli, Francesca;
Bruni, Cosimo;
Cometi, Laura;
Blagojevic, Jelena;
Fiori, Ginevra;
Tofani, Lorenzo;
Galluccio, Felice;
Furst, Daniel;
Matucci Cerinic, Marco

Publication type:

Article

Ultrasound7 versus ultrasound12 in monitoring the response to infliximab in patients with rheumatoid arthritis.

Published in:

Clinical Rheumatology, 2016, v. 35, n. 3, p. 587, doi. 10.1007/s10067-016-3176-2

By:

Leng, Xiaomei;
Xiao, Weiguo;
Xu, Zhonghui;
Zhu, Xiaochun;
Liu, Yi;
Zhao, Dongbao;
Xu, Huji;
Chen, Guoqiang;
Yu, Wei;
Lu, Jing;
Wang, Jiakai;
Xia, Xiaoru;
Li, Yongji;
Zhao, Yi;
Tang, Honghu;
Shi, Yeqing;
Bao, Jun;
Chen, Ling;
Lin, Li;
Zhou, Ling

Publication type:

Article

The metastasis-associated protein S100A4 may be a new potential therapeutic target for rheumatoid arthritis.

Published in:

2016

By:

He, Wei;
Xu, Xiao-Di;
Wu, Hua

Publication type:

Letter

Infliximab-induced autoantibodies: a multicenter study.

Published in:

Clinical Rheumatology, 2016, v. 35, n. 2, p. 325, doi. 10.1007/s10067-015-3140-6

By:

Vaz, João;
Fernandes, Vander;
Nogueira, Felipe;
Arnóbio, Adriano;
Levy, Roger

Publication type:

Article

Multicentric reticulohistiocytosis: case report with response to infliximab and review of treatment options.

Published in:

Clinical Rheumatology, 2016, v. 35, n. 2, p. 527, doi. 10.1007/s10067-014-2611-5

By:

Macía-Villa, Cristina;
Zea-Mendoza, Antonio

Publication type:

Article

Early-onset sarcoidosis caused by a rare CARD15/NOD2 de novo mutation and responsive to infliximab: a case report with long-term follow-up and review of the literature.

Published in:

2015

By:

La Torre, Francesco;
Lapadula, Giovanni;
Cantarini, Luca;
Lucherini, Orso;
Iannone, Florenzo

Publication type:

Case Study

Infliximab has no apparent effect in the inner ear hearing function of patients with rheumatoid arthritis and ankylosing spondylitis.

Published in:

Clinical Rheumatology, 2014, v. 33, n. 10, p. 1481, doi. 10.1007/s10067-014-2625-z

By:

Toktas, H.;
Okur, E.;
Dundar, U.;
Dikici, A.;
Kahveci, O.

Publication type:

Article

Survival of disease-modifying antirheumatic drugs used as the first antirheumatic medication in the treatment of ankylosing spondylitis in Finland. A nationwide population-based register study.

Published in:

Clinical Rheumatology, 2014, v. 33, n. 8, p. 1135, doi. 10.1007/s10067-014-2700-5

By:

Relas, Heikki;
Kautiainen, Hannu;
Puolakka, Kari;
Virta, Lauri;
Leirisalo-Repo, Marjatta

Publication type:

Article

The use of TNF-α blockers in psoriatic arthritis patients with latent tuberculosis infection.

Published in:

Clinical Rheumatology, 2014, v. 33, n. 4, p. 543, doi. 10.1007/s10067-014-2536-z

By:

Atteno, Mariangela;
Costa, Luisa;
Matarese, Alessandro;
Caso, Francesco;
Puente, Antonio;
Cantarini, Luca;
Bocchino, Maria;
Sanduzzi, Alessandro;
Scarpa, Raffaele

Publication type:

Article

Prednisolone combined with adjunctive immunosuppression is not superior to prednisolone alone in terms of efficacy and safety in giant cell arteritis: meta-analysis.

Published in:

Clinical Rheumatology, 2014, v. 33, n. 2, p. 227, doi. 10.1007/s10067-013-2384-2

By:

Yates, M.;
Loke, Y.;
Watts, R.;
MacGregor, A.

Publication type:

Article

The impact of conventional DMARD and biological therapies on CD4+ cell subsets in rheumatoid arthritis: a follow-up study.

Published in:

Clinical Rheumatology, 2014, v. 33, n. 2, p. 175, doi. 10.1007/s10067-013-2352-x

By:

Szalay, Balázs;
Vásárhelyi, Barna;
Cseh, Áron;
Tulassay, Tivadar;
Deák, Magdolna;
Kovács, László;
Balog, Attila

Publication type:

Article

Anti-TNF therapy in patients with HBV infection-analysis of 87 patients with inflammatory arthritis.

Published in:

Clinical Rheumatology, 2014, v. 33, n. 1, p. 119, doi. 10.1007/s10067-013-2385-1

By:

Ye, Hua;
Zhang, Xue-wu;
Mu, Rong;
Fang, Lin-kai;
Gu, Jie-ruo;
Lin, Jin;
Du, Jin-feng;
Chen, Jin-wei;
Chen, Yi-jia;
Wu, Li-jun;
Pang, Xue-feng;
Li, Zhan-guo

Publication type:

Article

Cost per responder of TNF-α therapies in Germany.

Published in:

Clinical Rheumatology, 2013, v. 32, n. 12, p. 1805, doi. 10.1007/s10067-013-2332-1

By:

Gissel, Christian;
Repp, Holger

Publication type:

Article

A case of infliximab-induced lupus in a patient with ankylosing spondylitis: is it safe switch to another anti-TNF-α agent?

Published in:

2013

By:

Santiago, Tânia;
Santiago, Mariana Galante;
Rovisco, João;
Duarte, Cátia;
Malcata, Armando;
da Silva, José António Pereira

Publication type:

Case Study

Tumor necrosis factor alpha inhibitors in patients with Takayasu's arteritis refractory to standard immunosuppressive treatment: cases series and review of the literature.

Published in:

Clinical Rheumatology, 2013, v. 32, n. 12, p. 1827, doi. 10.1007/s10067-013-2380-6

By:

Novikov, P. I.;
Smitienko, I. O.;
Moiseev, S. V.

Publication type:

Article

Absence of radiographic progression of hip arthritis during infliximab treatment for ankylosing spondylitis.

Published in:

Clinical Rheumatology, 2013, v. 32, n. 8, p. 1229, doi. 10.1007/s10067-013-2263-x

By:

Konsta, M.;
Sfikakis, P.;
Bournia, V.;
Karras, D.;
Iliopoulos, A.

Publication type:

Article

Precore mutant hepatitis B virus-associated fulminant hepatitis during infliximab therapy for rheumatoid arthritis.

Published in:

2013

By:

Kuwabara, Hiroko;
Fukuda, Akira;
Tsuda, Yasuhiro;
Shibayama, Yuro

Publication type:

Report

Infliximab improves bone metabolism and bone mineral density in rheumatoid arthritis and ankylosing spondylitis: a prospective 2-year study.

Published in:

2013

By:

Dischereit, Gabriel;
Tarner, Ingo;
Müller-Ladner, Ulf;
Lange, Uwe

Publication type:

Report

Clinical outcome in patients with rheumatoid arthritis switched to tocilizumab after etanercept or infliximab failure.

Published in:

Clinical Rheumatology, 2013, v. 32, n. 2, p. 253, doi. 10.1007/s10067-012-2118-x

By:

Wakabayashi, Hiroki;
Hasegawa, Masahiro;
Nishioka, Yosuke;
Minami, Yukari;
Nishioka, Kusuki;
Sudo, Akihiro

Publication type:

Article

Acute and long-term effect of infliximab on humoral and echocardiographic parameters in patients with chronic inflammatory diseases.

Published in:

Clinical Rheumatology, 2013, v. 32, n. 1, p. 61, doi. 10.1007/s10067-012-2091-4

By:

Tomáš, Ľubomír;
Lazúrová, Ivica;
Pundová, Lýdia;
Oetterová, Mária;
Zakuciová, Mária;
Petrášová, Darina;
Studenčan, Martin

Publication type:

Article

Subsequent entry biologics/biosimilars: a viewpoint from Canada.

Published in:

Clinical Rheumatology, 2012, v. 31, n. 9, p. 1289, doi. 10.1007/s10067-012-2066-5

By:

Russell, Anthony;
Ahluwalla, Vandana;
Barnabe, Cheryl;
Jamal, Shahin;
Offer, Robert;
Olszynski, Wojciech;
Shojania, Kam;
Haraoui, Boulos

Publication type:

Article

Infliximab therapy for familial Mediterranean fever-related amyloidosis: case series with long term follow-up.

Published in:

Clinical Rheumatology, 2012, v. 31, n. 8, p. 1267, doi. 10.1007/s10067-012-2009-1

By:

Özçakar, Z.;
Yüksel, Selçuk;
Ekim, Mesiha;
Yalçınkaya, Fatoş

Publication type:

Article

Refractory multisystem sarcoidosis responding to infliximab therapy.

Published in:

Clinical Rheumatology, 2012, v. 31, n. 6, p. 1013, doi. 10.1007/s10067-011-1933-9

By:

Croft, Adam;
Situnayake, Deva;
Khair, Omer;
Giovanni, Gavin;
Carruthers, David;
Sivaguru, Arul;
Gordon, Caroline

Publication type:

Article

Chilblain lupus induced by TNF-α antagonists: a case report and literature review.

Published in:

Clinical Rheumatology, 2012, v. 31, n. 3, p. 563, doi. 10.1007/s10067-011-1924-x

By:

Sifuentes Giraldo, Walter;
Ahijón Lana, María;
García Villanueva, María;
González García, Carmen;
Vázquez Diaz, Mónica

Publication type:

Article

Anti-TNF therapy for polymyalgia rheumatica: report of 99 cases and review of the literature.

Published in:

Clinical Rheumatology, 2012, v. 31, n. 3, p. 575, doi. 10.1007/s10067-011-1914-z

By:

Aikawa, Nádia;
Pereira, Rosa;
Lage, Laís;
Bonfá, Eloisa;
Carvalho, Jozélio

Publication type:

Article

Infliximab therapy efficacy and persistence at a Canadian academic centre despite a change in access procedure.

Published in:

Clinical Rheumatology, 2012, v. 31, n. 2, p. 211, doi. 10.1007/s10067-011-1803-5

By:

Barnabe, Cheryl;
Barr, Susan;
Martin, Liam

Publication type:

Article

Indirect comparison of etanercept, infliximab, and adalimumab for psoriatic arthritis: mixed treatment comparison using placebo as common comparator.

Published in:

Clinical Rheumatology, 2012, v. 31, n. 1, p. 133, doi. 10.1007/s10067-011-1790-6

By:

Migliore, Alberto;
Bizzi, Emanuele;
Broccoli, Serena;
Laganà, Bruno

Publication type:

Article

Errors noted in: Re: Migliore A, Bizzi E, Broccoli S Laganà (2011). Indirect comparison of etanercept, infliximab, and adalumimab for psoriatic arthritis: mixed treatment comparison using placebo as common comparator. Published on line June 21st 2011

Published in:

2011

By:

O'Regan, Christopher

Publication type:

Letter

Outcomes of switching anti-TNF drugs in rheumatoid arthritis-a study based on observational data from the Finnish Register of Biological Treatment (ROB-FIN).

Published in:

Clinical Rheumatology, 2011, v. 30, n. 11, p. 1447, doi. 10.1007/s10067-011-1779-1

By:

Virkki, Liisa;
Valleala, Heikki;
Takakubo, Yuya;
Vuotila, Jorma;
Relas, Heikki;
Komulainen, Riitta;
Koivuniemi, Riitta;
Yli-Kerttula, Urpo;
Mali, Markku;
Sihvonen, Susanna;
Krogerus, Maija-Liisa;
Jukka, Eero;
Nyrhinen, Satu;
Konttinen, Yrjö;
Nordström, Dan

Publication type:

Article

Is anti-TNF switching in refractory Still's disease safe and effective?

Published in:

Clinical Rheumatology, 2011, v. 30, n. 8, p. 1129, doi. 10.1007/s10067-011-1735-0

By:

Aikawa, Nadia;
Medeiros Ribeiro, Ana;
Saad, Carla;
Pereira, Rosa;
Levy, Mauricio;
Silva, Clovis;
Bonfá, Eloísa;
Carvalho, Jozélio

Publication type:

Article

Outcome of patients with seronegative spondyloarthritis continuing sulphasalazine and methotrexate after a short course of infliximab therapy-experience from a tertiary care teaching hospital in South India.

Published in:

Clinical Rheumatology, 2011, v. 30, n. 7, p. 997, doi. 10.1007/s10067-011-1723-4

By:

Sandhya, P.;
Danda, Debashish;
Mathew, John;
Gattani, Atul

Publication type:

Article

Infliximab for patients with neuro-Behcet's disease: case series and literature review.

Published in:

Clinical Rheumatology, 2011, v. 30, n. 7, p. 1007, doi. 10.1007/s10067-011-1726-1

By:

Borhani Haghighi, Afshin;
Safari, Anahid;
Nazarinia, Mohammad;
Habibagahi, Zahra;
Shenavandeh, Saeedeh

Publication type:

Article